Korro Bio Inc
(KRRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,605 | -58,032 | -64,218 | -44,671 | -23,386 |
| Depreciation Amortization | 741 | 2,366 | 2,094 | 1,415 | 726 |
| Accounts payable and accrued liabilities | 549 | 1,755 | 459 | 797 | -429 |
| Other Working Capital | -1,606 | -633 | 1,897 | 900 | -808 |
| Other Operating Activity | 232 | 899 | 17,150 | 10,738 | 6,554 |
| Operating Cash Flow | $-19,689 | $-53,645 | $-42,618 | $-30,821 | $-17,343 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,000 | 16,272 | N/A | N/A | N/A |
| PPE Investments | -1,513 | -5,136 | 18 | -16 | -12 |
| Purchase Of Investment | N/A | N/A | -46,914 | -38,108 | -20,786 |
| Sale Of Investment | N/A | N/A | 53,469 | 31,483 | 8,136 |
| Other Investing Activity | 0 | -76 | 0 | 0 | 0 |
| Investing Cash Flow | $15,487 | $11,060 | $6,573 | $-6,641 | $-12,662 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 51 | 62 | 256 | 200 | 200 |
| Other Financing Activity | 45,350 | -44 | 0 | 0 | 0 |
| Financing Cash Flow | $45,401 | $18 | $256 | $200 | $200 |
| Beginning Cash Position | 41,477 | 84,044 | 81,334 | 81,334 | 81,334 |
| End Cash Position | 82,676 | 41,477 | 45,545 | 44,072 | 51,529 |
| Net Cash Flow | $41,199 | $-42,567 | $-35,789 | $-37,262 | $-29,805 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,689 | -53,645 | -42,618 | -30,821 | -17,343 |
| Capital Expenditure | -1,513 | -5,136 | N/A | -16 | -12 |
| Free Cash Flow | -21,202 | -58,781 | -42,618 | -30,837 | -17,355 |